Daniel George

New research from Dan George, MD, & team emphasizes the importance of diversity in clinical trials after finding a particular drug combo was more successful in Black men.

Of 27 faculty from the School of Medicine awarded distinguished professorships this year, 10 are members of Duke Cancer Institute.

Here are some of the DCI faculty, researchers, and clinical providers whose work has recently been featured in the media, trades, journals, at Duke and the DCI blog.

Here are some of the DCI faculty, researchers, and clinical providers whose work has recently been featured in the media, trades, journals, at Duke and the DCI blog.

Here are some of the DCI faculty, researchers, and clinical providers whose work has recently been featured in the media, trades, journals, at Duke and the DCI blog.

Here are some of the DCI faculty, researchers, and clinical providers whose work has recently been featured in the media, trades, journals, at Duke and the DCI blog.

The Duke Med Alumni News Fall '22 Issue's cover story is "Researchers at Duke are Creating More Precise Approaches to Stopping Tumors."

Here are some of the DCI faculty, researchers, and clinical providers whose work has recently been featured in the media, trades, journals, at Duke and the DCI blog.

The 2022 Shingleton Society dinner honored four awardees for their service in advancing the fight against cancer and paid video tribute to Cancer Center founder William Shingleton, MD.

Here are some of the DCI faculty, researchers, and clinical providers whose work has recently been featured in the media, trades, journals, at Duke and the DCI blog.

Here are some of the DCI faculty, researchers, and clinical providers whose work has recently been featured in the media, trades, journals, at Duke and the DCI blog.

Here are some of the DCI faculty, researchers, and clinical providers whose work has recently been featured by the media, academic trade publications & journals.

Donor support is helping more men receive screening, education, and follow-up care to detect and treat prostate cancer earlier, when it's more curable. 

The Victory Ride returned as an in-person cycling event on May 21. 2021 V Ride funds go to a grant for American Indian cancer health disparities research. 

Here are some of the DCI faculty, researchers and nurses whose work has recently been featured by the media, academic trade publications & journals.

Having a relationship with your doctor matters, accordng to patient Art Cain.

Here are some of the DCI faculty, researchers and nurses whose work has recently been featured by the media, academic trade publications & journals.

The V Foundation's Victory Ride to Cure Cancer was back as a LIVE cycling event and celebration, Aug. 28. Team DCI "virtual" and in-person riders raised more than $20K.

Here are some of the DCI faculty, researchers and nurses whose work has recently been featured by the media, academic trade publications & journals.

Enrolling a large number of Black men, Duke researchers found potential new paths for improved studies and treatments.

DCI faculty Daniel George, MD, has been named a Fellow of the American Society of Clinical Oncology.

Here are some of the DCI faculty, researchers and nurses whose work has recently been featured by the media, academic trade publications & journals.

Various genetic alterations in circulating tumor cells were associated with clinical outcomes and resistance to hormone therapy in patients with mCRPC.

Current issues and technologies for diagnosis and treatment in urology and urologic oncology will be addressed.

The finding points toward a new approach that directly targets the cancer’s fuel source.

A research team led by Andrew Armstrong, MD, MSc, identifies new targets for treating non-clear cell renal carcinoma.

Here are some of the DCI faculty, researchers and nurses whose work has recently been featured by the media, academic trade publications & journals.

DCI director Michael B. Kastan, MD, PhD, announced a planned reconfiguration of DCI’s NCI-Designated Research Programs and welcomed new research leaders.

Here are some of the DCI faculty, researchers and nurses whose work has recently been featured by the media, academic trade publications & journals.

Here are some of the DCI faculty, researchers and nurses whose work has recently been featured by the media, academic trade publications & journals.

Here are some of the DCI faculty, researchers and nurses whose work has recently been featured by the media, academic trade publications & journals.

On-demand viewing of AACR Annual Meeting sessions is now available. Duke presenters included Hema Adhikari, PhD, and Daniel George, MD.

Duke Cancer Institute welcomes a new clinical investigator specializing in bladder cancer to its Genitourinary Oncology program.

Here are some of the DCI physicians, physician-scientists, researchers & nurses whose work has recently been featured by the media, academic trade publications & journals.

Here's a sample of some of the DCI physicians, physician-scientists, researchers and nurses whose work is featured by the media and in academic journals.

Here's a sample of some of the DCI physicians, physician-scientists, researchers and nurses whose work is featured by the media and in academic journals.

Here's a sample of some of the DCI physicians, physician-scientists, researchers and nurses whose work is featured by the media and in academic journals.

Here's a sample of some of the DCI physicians, physician-scientists, researchers and nurses whose work is featured by the media and in academic journals.

This October Newsmakers has many of the latest articles, papers, and videos on breast cancer featuring our faculty. It's also chock full of other faculty newsmakers.

Duke Cancer Institute hematologic oncologist Joseph Moore, MD, after 44 years, retired from clinical practice this summer. He and colleagues reflect on his legacy.

Here's a sample of some of the DCI physicians, physician-scientists, researchers and nurses whose work is featured by the media and in academic journals.

Here's a sample of some of the DCI physicians, physician-scientists, researchers and nurses whose work is featured by the media and in academic journals.

Most studies of new treatments don't reflect the diversity of people in the real world. That's a problem our researchers are finding new ways to solve.

Black men are underrepresented in clinical trials for prostate cancer, despite an almost two-fold greater incidence and mortality of disease in black versus white populations.

When his dad passed away from cancer, Myles Owens IV launched a clothing line in his memory. Part of the proceeds benefit Duke Cancer Institute research.